Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Rapid molecular diagnostics have potential to revolutionize patient care
• CDC: Haiti makes substantial progress since 2010 earthquake
• CDC: Severe flu season continues; antivirals underused
• Clusters of underimmunized, vaccine-refusal communities identified in California
• Five vaccines required of US-bound refugees
• HPV vaccination did not increase MS risk in females
• NFID: Recommend HPV vaccine strongly with other routine vaccines
• RCT alternatives useful, but require careful consideration
• WHO approves meningitis A vaccine for infants in sub-Saharan Africa
• WHO resolves to improve response to public health emergencies
• Disneyland measles outbreak spreads; AAP urges vaccination
• The power of mentoring: We all can help recruit more ID specialists Stephen B. Calderwood, MD
• MERS: The limping epidemic on steroids Donald Kaye, MD, MACP; Marjorie P. Pollack, MD
• Antibiotics for travelers' diarrhea may lead to spread of superbugs
• ART timing during pregnancy linked to detectable viral load at delivery
• Beclabuvir with PEG-IFN a-2a/Ribavirin Safely Treated HCV
• Bundled intervention reduced KPC infection, colonization
• CD4 counts at HIV diagnosis remain low in Africa
• CDC: Link between EV-D68, neurologic illness unverified
• CDC: Only one confirmed occupationally acquired HIV case reported since 1999
• Child's death linked to N. fowleri in treated tap water
• Clarithromycin associated with adverse outcomes with non-CYP3A4–metabolized statins
• Cognitive impairment associated with HCV in children
• Daily chlorhexidine bathing in ICU did not reduce HAIs
• Ebola epidemic likely stemmed from contact with insectivorous bats
• Ebola virus mutations may hinder new treatments
• Electronic reminder increased influenza vaccination rates in late winter
• Experts warn widespread HCV screening harms may outweigh benefits
• Family members likely sources of RSV in infants
• HCV mortality rates stabilized or increased across three regions
• High-dose flu vaccine demonstrated superior response in frail, elderly
• Higher levels of inflammatory markers found in elite controllers
• Hospitalization rates greater among elite controllers
• ICU infection prevention programs reduced costs, improved survival
• Inclusion of vaccine education improved efficacy of text message reminders
• Infection control efforts in Hong Kong hospital prevented H7N9 transmission
• Injectable contraceptive associated with increased risk for HIV acquisition
• Interferon-free regimen well tolerated in HIV/HCV coinfected patients
• Intervention program increased expedited partner therapy use
• Kaiser: Elevated MI risk for HIV patients eliminated
• MERS transmissibility from camels to humans appeared low
• Micafungin noninferior to standard prophylaxis after liver transplantation
• Monthly treatment reduced risk for recurrent bacterial vaginosis
• MRSA infections increased risk for death after discharge
• Oseltamivir reduced influenza symptoms, complications in adults
• PCV13 safe, immunogenic in previously vaccinated HIV patients
• Pneumonia possible risk factor for CVD
• Positive nanoparticle charge increased pulmonary immunization efficacy
• Rate of US medical research investment drops
• Researchers map chikungunya spread in Panama
• Resistance by PrEP linked to acute seronegative infections at initiation
• RSV may increase risk for bacterial pneumonia in infants
• Sexual behaviors between women affected acquisition of bacterial vaginosis
• Shared genes identified between chicken virus, H7N9 in China
• Software predicted development of bacterial resistance
• Some treatments for cystic echinococcosis considered medically unsound
• Spider bites 'scapegoat' for cutaneous bacterial infection
• Tetravalent dengue vaccine safe, effective in Latin American children
• Triple-drug regimen led to high HCV cure rate
• Universal HCV screening in Canada could be cost effective, save lives
• Hearing deficiency detected among people with HIV
• The polymyxins: Renewed interest in old antibiotics Kimberly Boeser, PharmD, MPH, BCIDP; Brent Bastian, PharmD, MS